EUVIMEDEUVIMED entdecken
Crossref

Bioorthogonal Aptamer‐ATTEC Conjugates for Degradation of Alpha‐Synuclein via Autophagy‐Lysosomal Pathway

Xiaofeng Liao, Geng Qin, Zhenqi Liu, Jinsong Ren, Xiaogang Qu iD

Small · 2024-02 · 20 (8)

DOI: 10.1002/smll.202306760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 11.10.2023. Verfasst von Xiaofeng Liao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy…. Hauptthemen laut MEDLINE: alpha-Synuclein, Autophagosomes. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagosome‐tethering compound (ATTEC) technology has recently been emerging as a novel approach for degrading proteins of interest (POIs). However, it still faces great challenges in how to design target‐specific ATTEC molecules. Aptamers are single‐stranded DNA or RNA oligonucleotides that can recognize their target proteins with high specificity and affinity. Here, ATTEC is combined with aptamers for POIs degradation. As a proof of concept, pathological protein α‐synuclein (α‐syn) is chosen as the target and an efficient α‐syn degrader is generated. Aptamer as a targeting warhead of α‐syn is conjugated with LC3B‐binding compound 5,7‐dihydroxy‐4‐phenylcoumarin (DP) via bioorthogonal click reaction. It is demonstrated that the aptamer conjugated with DP is capable of clearing α‐syn through LC3 and autophagic degradation. These results indicate that aptamer‐based ATTECs are a versatile approach to degrade POIs by taking advantage of the well‐defined different aptamers for targeting diverse proteins, which provides a new way for the design of ATTECs to degradation of targeted proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinAutophagosomesAutophagyLysosomesOligonucleotides

Stichwörter der Autor:innen

Parkinson's diseaseautophagic degradationautophagosome-tethering compoundstargeted protein degradationα-synuclein

Substanzen

alpha-SynucleinOligonucleotides

Autor:innen und Institutionen

  • Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.
  • School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.

ORCID-Profile: Xiaogang Qu

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Liao, X., Qin, G., Liu, Z., Ren, J., & Qu, X. (2024). Bioorthogonal Aptamer‐ATTEC Conjugates for Degradation of Alpha‐Synuclein via Autophagy‐Lysosomal Pathway. Small, 20(8). https://doi.org/10.1002/smll.202306760

Vancouver

Liao X, Qin G, Liu Z, Ren J, Qu X. Bioorthogonal Aptamer‐ATTEC Conjugates for Degradation of Alpha‐Synuclein via Autophagy‐Lysosomal Pathway. Small. 2024;20(8). doi:10.1002/smll.202306760

BibTeX
@article{Liao2024,
  author = {Liao, Xiaofeng and Qin, Geng and Liu, Zhenqi and Ren, Jinsong and Qu, Xiaogang},
  title = {Bioorthogonal Aptamer‐ATTEC Conjugates for Degradation of Alpha‐Synuclein via Autophagy‐Lysosomal Pathway},
  journal = {Small},
  year = {2024},
  volume = {20},
  number = {8},
  doi = {10.1002/smll.202306760}
}
Kostenlos starten →